Development of statistical machine learning method for pearsonalized medichine in caner research
Project/Area Number |
23700334
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Statistical science
|
Research Institution | University of Yamanashi |
Principal Investigator |
|
Project Period (FY) |
2011-04-28 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2014: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2013: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2012: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Keywords | 樹木構造接近法 / 多変量適応型回帰スプライン / ルールアンサンブル法 / 縮小推定 / がん臨床研究 / 個別化医療 / ABLE法 / 競合リスク / 生存時間研究 / ルール・アンサンブル法 / 自動2値ロジスティック推定法 / 時間依存型ROC曲線 / 多変量適応型回帰スプライン法 / 比例オッズ・モデル / 比例ハザード・モデル / 生存時間解析 / 時間依存型ROC曲線 / ロジスティック回帰 / 予後・予測因子の評価 / アンサンブル学習法 / 極限回帰法 / 交互作用 |
Outline of Final Research Achievements |
In our study, we developed newly statistical models for a personalized medicine in cancer research. We focused on two kind of statistical approaches: (1) predictive performance approach, and (2) easily interpretative approach. In former approach, we developed the rule ensemble method for survival outcome. Our proposed method and applications were given two kind of awards. In later approach, we developed the adaptive index model and adaptive step function model for survival outcome. Moreover, we wrote textbook about tree based method.
|
Report
(5 results)
Research Products
(65 results)
-
-
-
-
[Journal Article] Factors associated with technical difficulties and adverse events of colorectal endoscopic submucosal dissection: retrospective exploratory factor analysis of a multicenter prospective cohort2014
Author(s)
Takeuchi Y, Iishi H, Tanaka S, Saito Y, Ikematsu H, Kudo SE, Sano Y, Hisabe T, Yahagi N, Saitoh Y, Igarashi M, Kobayashi K, Yamano H, Shimizu S, Tsuruta O, Inoue Y, Watanabe T, Nakamura H, Fujii T, Uedo N, Shimokawa T, Ishikawa H, Sugihara K.
-
Journal Title
Int J Colorectal Dis.
Volume: 29(10)
Issue: 10
Pages: 1275-1284
DOI
Related Report
Peer Reviewed
-
-
-
-
-
[Journal Article] Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy2014
Author(s)
K. Fujitani, S. Tamura, Y. Kimura, T. Tsuji, J. Matsuyama, S. Iijima, H. Imamura,K. Inoue, K. Kobayashi, Y. Kurokawa, T. Shimokawa, T. Tsujinaka, H. Furukawa
-
Journal Title
Gastric Cancer
Volume: 17(2)
Issue: 2
Pages: 348-353
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
[Journal Article] Subcuticular sutures versus staples for skin closure with open gastrointestinal surgery: a phase 3 multicentre, open-label, randomized controlled trial2013
Author(s)
T. Tsujinaka, K. Yamamoto, J. Fujita, S. Endo, J. Kawada, S. Nakahira, T. Shimokawa, S. Kobayashi, M. Yamasaki, Y. Akamaru, A. Miyamoto, T. Mizushima, J. Shimizu, K. Umeshita, T. Ito, Y. Doki, M. Mori
-
Journal Title
The Lancet
Volume: 382
Issue: 9898
Pages: 1105-1112
DOI
Related Report
Peer Reviewed
-
-
-
[Journal Article] A Phase I study of triplet combination chemotherapy of paclitaxel, cisplatin and S-1 in patients with advanced gastric cancer2013
Author(s)
Y. Kimura, H. Yano, H. Imamura, K. Fujitani, M. Imano, Y. Tokunaga, M. Matsuoka, Y. Kurokawa, T. Shimokawa, H. Takiuchi, T. Tsujinaka, H. Furukawa
-
Journal Title
Japanese Journal of Clinical Oncology
Volume: 43(2)
Issue: 2
Pages: 125-131
DOI
Related Report
Peer Reviewed
-
[Journal Article] A Phase I/II Trial of Radiotherapy Concurrent with TS-1 Plus Cisplatin in Patients with Clinically Resectable Type 4 or Large Type 3 Gastric Cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG12052013
Author(s)
M. Imano, H. Furukawa, M. Yokokawa, Y. Nishimura, Y. Kurokawa, T. Satoh, D. Sakai, T. Yasuda, H. Imamoto, T. Tsujinaka, T. Shimokawa, H. Shiozaki
-
Journal Title
Japanese Journal of Clinical Oncology
Volume: 43(4)
Issue: 4
Pages: 431-435
DOI
Related Report
Peer Reviewed
-
-
-
-
[Journal Article] Intraoperative versus extended antimicrobial prophylaxis after gastric cancer surgery: a phase 3, open-label, randomised controlled, non-inferiority trial2012
Author(s)
H. Imamura, Y. Kurokawa, T. T., K. Inoue, Y. Kimura, S. Iijima, T. Shimokawa, H. Furukawa
-
Journal Title
The Lancet Infectious Disease
Volume: 12(5)
Issue: 5
Pages: 381-387
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
[Journal Article] Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer2011
Author(s)
K. Inoue, Y Nakane, M. Kogire, K. Fujita, Y. Kimura, H. Imamura, S. Tamura, S. Okano, AH Kwon, Y. Kurokawa, T. Shimokawa, H. Takiuchi, T Tsujinaka, H. Furukawa
-
Journal Title
Eur. J. Surg. Oncol.
Volume: 38(2)
Pages: 143-149
Related Report
Peer Reviewed
-
-
-
-
-
-
[Presentation] A phase II study of panitumumab plus irinotecan for metastatic colorectal cancer with wild KRAS, resistant to fluoropyrimidine, oxaliplatin, and irinotecan in Japanese. Osaka Gastrointestinal cancer chemotherapy Study Group: OGSG10012014
Author(s)
K. Taira, M. Yoshida, N. Sugimoto, T. Kii, S. Kuwakado, M. Fukunaga, H. Hasegawa, T. Kato, Y. Miyake, T. Hata, Y. Tokunaga, K. Takeda, H. Daga, T. Yoshinami, T. Shimokawa, D. Sakai, Y. Kurokawa, T. Satoh, T. Tsujinaka, H. Furukawa
Organizer
2014 Gastrointestinal Cancers Symposium, ASCO
Place of Presentation
San Francisco, USA
Related Report
-
[Presentation] Evaluation of the effects of postoperative oral nutrition support on body weight in gastric cancer patients by using an elemental diet: A randomized study (KSES 001)2014
Author(s)
K. Nishikawa, K. Kishi, K. Inoue, J. Matsuyama, Y. Akamaru, Y. Kimura, S. Tamura, R. Kawabata, J. Kawada, Y. Fujiwara, T. Kawase, J. Fukui, M. Takagi, A. Takeno, T. Shimokawa, H. Imamura
Organizer
2014 Gastrointestinal Cancers Symposium, ASCO
Place of Presentation
San Francisco, USA
Related Report
-
[Presentation] Updated analysis of HERBIS-1: A phase ll study of trastuzumab (T-mab) in combination with tri-weekly S-1 plus CDDP in HER2-positive advanced gastric cancer2014
Author(s)
M. Gamoh, N. Sugimoto, H. Miwa, M. Tsuda, S. Nishina, H. Okuda, H. Imamura, J. Matsuyama, T. Shimokawa, D. Sakai, Y. Kurokawa, Y. Komatsu,T. Tsujinaka, C. Ishioka, H. Furukawa
Organizer
2014 Gastrointestinal Cancers Symposium, ASCO
Place of Presentation
San Francisco, USA
Related Report
-
-
[Presentation] A phase ll study of new combination regimen with trastuzumab, S-1, and CDDP in HER2-positive advanced gastric cancer (HERBIS-1)2013
Author(s)
K. Koeda, N. Sugimoto, J. Tanaka, M. Tsuda, W. Okamoto, H. Okuda, H. Imamura, J. Matsuyama, T. Shimokawa, D. Sakai, N. Fukushima, Y. Kurokawa, Y. Komatsu, T. Tsujinaka, H. Furukawa
Organizer
2013 ASCO Annual Meeting
Place of Presentation
Chicago, USA
Related Report
-
-
-
-
-
-
[Presentation] Impact of pretreatment systemic inflammatory response on survival in AGC patients receiving first-line chemotherapy2013
Author(s)
K. Fujitani, H. Takiuchi, N. Sugimoto, H. Imamura, S. Iijima, M. Imano, Y. Kimura, Y. Kurokawa, T. Shimokawa, T. Tsujinaka, H. Furukawa
Organizer
2013 Gastrointestinal Cancers Symposium, ASCO
Place of Presentation
San Francisco,USA
Related Report
-
[Presentation] A phase ll study of trastuzumab in combination with triweekly S-1 plus CDDP in HER2-positive advanced gastric cancer (HERBIS-1)2013
Author(s)
N. Sugimoto, J. Tanaka, M. Tsuda, W. Okamoto, H. Okuda, H. Imamura, T. Shimokawa, D. Sakai, Y. Kurokawa, Y. Komatsu, C. Ishioka, T. Tsujinaka, H. Takiuchi, H. Furukawa
Organizer
2013 Gastrointestinal Cancers Symposium, ASCO
Place of Presentation
San Francisco,USA
Related Report
-
[Presentation] Randomized phase II study of 6 versus 12 months of adjuvant imatinib for patients with intermediate- or high-risk GIST2013
Author(s)
K. Muguruma, Y. Kurokawa, T. Tsujinaka, J. Fujita, T. Nakai, A. Takabayashi, M. Hiramatsu, M. Terashima, Y. Iwasaki, J. Hasegawa, T. Kira, T. Shimokawa, S. Hirota, T. Nishida
Organizer
2013 Gastrointestinal Cancers Symposium, ASCO
Place of Presentation
San Francisco,USA
Related Report
-
-
-
-
-
-
[Presentation] Multicenter phase II study of triplet combination chemotherapy with paclitaxel, cisplatin, and S-1 for advanced gastric cancer (OGSG 0703)2012
Author(s)
K. Fujitani, Y. Kimura, H. Imamura, M. Gotoh, S. Iijima, S. Ueda, M. Imano, M. Oshita, Y. Kurokawa, T. Shimokawa, H. Takiuchi, T. Tsujinaka, and H. Furukawa
Organizer
ASCO GI 2012
Place of Presentation
San Francisco, USA
Related Report
-
-
-
-
-
-
-
-
-
-
-